ANGIODYNAMICS INC — insider transactions
51 transactions on record · ANGO · CIK 1275187
Aggregates
computed from the filings belowPurchases, 12m
0
count of open-market buys
Sales, 12m
51
count of open-market sales
Buy / sell ratio, 12m
0.00
purchases per sale
Distinct insiders, 12m
13
Bought, 3m
$0
Sold, 3m
$2M
Median disclosure lag
4.0 d
trade date to filing date
Largest single trade, 24m
$369.4K
2026-07-22
Director share, 12m
29.4%
of transactions where role is stated
Current run
51 sells
consecutive same-direction transactions
Net 3m flow
-$2M
purchases minus sales
Total on record
51
Transactions
51 most recent shown| Disclosed | Traded | Lag, d | Insider | Role | Transaction | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-31 | 2026-07-30 | 1 | Nighan Warren JR | SVP Quality and Regulatory | Open market sale | 23,370 | $14.72 | $344K | filing |
| 2026-07-24 | 2026-07-22 | 2 | Campbell Chad Thomas | SVP/GM, Vascular Access | Exercise of derivative | 6,466 | $0.00 | — | filing |
| 2026-07-24 | 2026-07-22 | 2 | Campbell Chad Thomas | SVP/GM, Vascular Access | Exercise of derivative | 22,768 | $0.00 | — | filing |
| 2026-07-24 | 2026-07-22 | 2 | Clemmer James C | Director, President and CEO | Exercise of derivative | 52,358 | $0.00 | — | filing |
| 2026-07-24 | 2026-07-22 | 2 | Clemmer James C | Director, President and CEO | Exercise of derivative | 184,361 | $0.00 | — | filing |
| 2026-07-24 | 2026-07-22 | 2 | Trowbridge Stephen A | EVP and CFO | Exercise of derivative | 16,296 | $0.00 | — | filing |
| 2026-07-24 | 2026-07-22 | 2 | Trowbridge Stephen A | EVP and CFO | Exercise of derivative | 57,381 | $0.00 | — | filing |
| 2026-07-24 | 2026-07-22 | 2 | Nighan Warren JR | SVP Quality and Regulatory | Exercise of derivative | 5,694 | $0.00 | — | filing |
| 2026-07-24 | 2026-07-22 | 2 | Nighan Warren JR | SVP Quality and Regulatory | Exercise of derivative | 20,052 | $0.00 | — | filing |
| 2026-07-24 | 2026-07-22 | 2 | Piccinini Laura | SVP International | Exercise of derivative | 8,047 | $0.00 | — | filing |
| 2026-07-24 | 2026-07-22 | 2 | Piccinini Laura | SVP International | Exercise of derivative | 28,336 | $0.00 | — | filing |
| 2026-07-24 | 2026-07-22 | 2 | Campbell Chad Thomas | SVP/GM, Vascular Access | Shares withheld for tax | 2,330 | $13.82 | $32.2K | filing |
| 2026-07-24 | 2026-07-22 | 2 | Clemmer James C | Director, President and CEO | Shares withheld for tax | 26,728 | $13.82 | $369.4K | filing |
| 2026-07-24 | 2026-07-22 | 2 | Trowbridge Stephen A | EVP and CFO | Shares withheld for tax | 8,319 | $13.82 | $115K | filing |
| 2026-07-24 | 2026-07-22 | 2 | Nighan Warren JR | SVP Quality and Regulatory | Shares withheld for tax | 1,671 | $13.82 | $23.1K | filing |
| 2026-07-24 | 2026-07-22 | 2 | Piccinini Laura | SVP International | Shares withheld for tax | 4,506 | $13.82 | $62.3K | filing |
| 2026-07-22 | 2026-07-15 | 7 | Weiss Lawrence T | SVP, Chief Legal Officer | Grant or award | 21,288 | $0.00 | — | filing |
| 2026-07-22 | 2026-07-15 | 7 | Campbell Chad Thomas | SVP/GM, Vascular Access | Grant or award | 16,081 | $0.00 | — | filing |
| 2026-07-22 | 2026-07-15 | 7 | Piccinini Laura | SVP International | Grant or award | 19,860 | $0.00 | — | filing |
| 2026-07-22 | 2026-07-15 | 7 | Trowbridge Stephen A | EVP and CFO | Grant or award | 53,257 | $0.00 | — | filing |
| 2026-07-22 | 2026-07-15 | 7 | Auen Eileen O'Shea | Director | Grant or award | 11,887 | $0.00 | — | filing |
| 2026-07-22 | 2026-07-15 | 7 | Licitra Karen A | Director | Grant or award | 11,887 | $0.00 | — | filing |
| 2026-07-22 | 2026-07-15 | 7 | Weiss Lawrence T | SVP, Chief Legal Officer | Grant or award | 21,288 | $0.00 | — | filing |
| 2026-07-22 | 2026-07-15 | 7 | Nighan Warren JR | SVP Quality and Regulatory | Grant or award | 17,966 | $0.00 | — | filing |
| 2026-07-22 | 2026-07-15 | 7 | Piccinini Laura | SVP International | Grant or award | 19,860 | $0.00 | — | filing |
| 2026-07-22 | 2026-07-15 | 7 | Tarnoff Michael E | Director | Grant or award | 11,887 | $0.00 | — | filing |
| 2026-07-22 | 2026-07-15 | 7 | DONNELLY HOWARD W | Director | Grant or award | 11,887 | $0.00 | — | filing |
| 2026-07-22 | 2026-07-15 | 7 | REED JAN STERN | Director | Grant or award | 11,887 | $0.00 | — | filing |
| 2026-07-22 | 2026-07-15 | 7 | Campbell Chad Thomas | SVP/GM, Vascular Access | Grant or award | 16,081 | $0.00 | — | filing |
| 2026-07-22 | 2026-07-15 | 7 | Nighan Warren JR | SVP Quality and Regulatory | Grant or award | 17,966 | $0.00 | — | filing |
| 2026-07-22 | 2026-07-15 | 7 | Trowbridge Stephen A | EVP and CFO | Grant or award | 53,257 | $0.00 | — | filing |
| 2026-07-22 | 2026-07-15 | 7 | Burgess Lorinda | Director | Grant or award | 11,887 | $0.00 | — | filing |
| 2026-07-22 | 2026-07-15 | 7 | JOHNSON WESLEY | Director | Grant or award | 11,887 | $0.00 | — | filing |
| 2026-07-21 | 2026-07-17 | 4 | Campbell Chad Thomas | SVP/GM, Vascular Access | Shares withheld for tax | 1,112 | $13.51 | $15K | filing |
| 2026-07-21 | 2026-07-19 | 2 | Clemmer James C | Director, President and CEO | Shares withheld for tax | 11,764 | $13.51 | $158.9K | filing |
| 2026-07-21 | 2026-07-17 | 4 | Nighan Warren JR | SVP Quality and Regulatory | Shares withheld for tax | 1,373 | $13.51 | $18.5K | filing |
| 2026-07-21 | 2026-07-20 | 1 | Piccinini Laura | SVP International | Shares withheld for tax | 616 | $13.71 | $8.4K | filing |
| 2026-07-21 | 2026-07-16 | 5 | Trowbridge Stephen A | EVP and CFO | Shares withheld for tax | 7,840 | $14.14 | $110.9K | filing |
| 2026-07-21 | 2026-07-16 | 5 | Campbell Chad Thomas | SVP/GM, Vascular Access | Shares withheld for tax | 2,367 | $14.14 | $33.5K | filing |
| 2026-07-21 | 2026-07-17 | 4 | Clemmer James C | Director, President and CEO | Shares withheld for tax | 10,649 | $13.51 | $143.9K | filing |
| 2026-07-21 | 2026-07-20 | 1 | Clemmer James C | Director, President and CEO | Shares withheld for tax | 4,223 | $13.71 | $57.9K | filing |
| 2026-07-21 | 2026-07-16 | 5 | Nighan Warren JR | SVP Quality and Regulatory | Shares withheld for tax | 2,153 | $14.14 | $30.4K | filing |
| 2026-07-21 | 2026-07-17 | 4 | Piccinini Laura | SVP International | Shares withheld for tax | 3,074 | $13.51 | $41.5K | filing |
| 2026-07-21 | 2026-07-20 | 1 | Trowbridge Stephen A | EVP and CFO | Shares withheld for tax | 717 | $13.71 | $9.8K | filing |
| 2026-07-21 | 2026-07-16 | 5 | Weiss Lawrence T | SVP, Chief Legal Officer | Shares withheld for tax | 2,267 | $14.14 | $32.1K | filing |
| 2026-07-21 | 2026-07-20 | 1 | Campbell Chad Thomas | SVP/GM, Vascular Access | Shares withheld for tax | 359 | $13.71 | $4.9K | filing |
| 2026-07-21 | 2026-07-16 | 5 | Clemmer James C | Director, President and CEO | Shares withheld for tax | 18,588 | $14.14 | $262.8K | filing |
| 2026-07-21 | 2026-07-19 | 2 | Clemmer James C | Director, President and CEO | Shares withheld for tax | 487 | $13.51 | $6.6K | filing |
| 2026-07-21 | 2026-07-20 | 1 | Nighan Warren JR | SVP Quality and Regulatory | Shares withheld for tax | 251 | $13.71 | $3.4K | filing |
| 2026-07-21 | 2026-07-16 | 5 | Piccinini Laura | SVP International | Shares withheld for tax | 4,538 | $14.14 | $64.2K | filing |
| 2026-07-21 | 2026-07-17 | 4 | Trowbridge Stephen A | EVP and CFO | Shares withheld for tax | 3,510 | $13.51 | $47.4K | filing |